Expel Blend
EXPEL Blend Product Description — Research Use Only
EXPEL Blend is a research-use antiparasitic compound blend containing Fenbendazole (74MG) and Ivermectin (4MG). It is not a peptide blend; both ingredients are antiparasitic agents commonly studied for parasite-related pathways, organism clearance models, neuromuscular disruption, microtubule interference, and host-parasite interaction research.
Research on Fenbendazole has most commonly focused on parasite metabolism, microtubule disruption, tubulin binding, cellular transport interference, and helminth research. Fenbendazole is described as a benzimidazole compound that binds parasite beta-tubulin, disrupting microtubule formation and cellular function.
Research on Ivermectin has most commonly focused on parasite nerve signaling, glutamate-gated chloride channels, neuromuscular paralysis pathways, parasite motility, and internal/external parasite models. Ivermectin is known to interact with glutamate-gated chloride channels in nematodes and related organisms, leading to disrupted nerve and muscle function.
EXPEL Blend is commonly studied for:
Parasite research — how antiparasitic compounds affect parasite activity
Microtubule disruption — how Fenbendazole interferes with parasite cell structure
Nerve signaling — how Ivermectin affects parasite nerve and muscle activity
Motility studies — how parasite movement and function are reduced
Helminth research — studies involving worm-like parasite models
Compound-combination research — how two antiparasitic agents behave in the same research setting
Host-parasite pathways — how organisms respond during parasite-related research models
EXPEL Blend is commonly studied because Fenbendazole and Ivermectin act through different antiparasitic pathways. Fenbendazole is mainly associated with tubulin and microtubule interference, while Ivermectin is mainly associated with parasite nerve-channel signaling and neuromuscular disruption. This makes the blend relevant for controlled laboratory research involving parasite biology, compound-response studies, and antiparasitic mechanism comparison.
For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application. Fenbendazole is not FDA-approved for human use, and Ivermectin products should only be used as approved and directed by licensed professionals.